The apparent plateau is short-term, the data incomplete and the share of people with severe obesity still rising. The ...

This would not be the first time that public-health experts have prematurely celebrated the peak of America’s obesity crisis.

New criteria that put greater emphasis on body composition to diagnose obesity show greater prevalence of the disease in the ...

The Trump administration is making a significant effort to reduce the cost of weight loss drugs. Its agreement with ...

Surprised researchers discover hormone-sensitive lipase in the nuclei of fat cells, part of a finely tuned system that ...

Obesity severity is incrementally associated with a broad range of cardiometabolic and renal disease burden, as discovered by ...

For the first time in more than a decade, the number of states with rates of obesity of 35% or more dropped, a sign that ...

Key Takeaways A new AGA poll, funded by drug maker Novo Nordisk, shows that a large majority of Americans view obesity as a ...

With new agreements from President Donald Trump promising lower prices on popular weight-loss drugs, the use of GLP-1 medications such as Ozempic and Mounjaro could soon surge even higher.

The guidance, issued in a cable sent by the State Department to embassy and consular officials, directs visa officers to weed ...

Novo Nordisk A/S is undercutting arch-rival Eli Lilly & Co. on obesity drugs for cash-pay patients, showing its willingness ...